---
title: "BIOXYTRAN, INC. finishes $1.2M private funding round."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279951419.md"
description: "BIOXYTRAN, INC. has successfully completed a $1.2 million private funding round. In related economic news, the unemployment rate has dropped to 3.8%, the lowest in five years, with 250,000 new jobs created. GDP growth for the last quarter is at 5.2%, exceeding expectations. Analysts anticipate further decreases in unemployment if job creation continues, and the government is pleased with the economic progress, aiming to sustain this growth."
datetime: "2026-03-20T13:07:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279951419.md)
  - [en](https://longbridge.com/en/news/279951419.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279951419.md)
generator: "portal-rs"
---

# BIOXYTRAN, INC. finishes $1.2M private funding round.

In the latest report, it has been revealed that the unemployment rate in the country has decreased to 3.8%, the lowest figure recorded in the past five years. This positive development has led to the creation of 250,000 new jobs in various sectors. Additionally, the GDP growth for the last quarter stands at 5.2%, surpassing the previous estimate of 4.7%. Analysts predict a further drop in the unemployment rate in the upcoming months if this trend of job creation continues. The government has expressed satisfaction with the economic progress and aims to focus on sustaining this growth in the future.

### Related Stocks

- [BIXT.US](https://longbridge.com/en/quote/BIXT.US.md)

## Related News & Research

- [Bioxytran reports functional gains in first CIDP patient treated with PLICID galectin antagonist](https://longbridge.com/en/news/295525258.md)
- [BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT | BIXT Stock News](https://longbridge.com/en/news/279949045.md)
- [Bioxytran says Phase 2 trial of ProLectin-M drives SARS-CoV-2 viral load below detection by day seven](https://longbridge.com/en/news/294811633.md)
- [Bioxytran Q2 net loss turns to $619,929; H1 net loss widens to $2.69 million](https://longbridge.com/en/news/295970720.md)
- [BIOXYTRAN, INC 1Q 2026: Net loss $(2.07M), EPS $(0.02) — 10-Q Summary](https://longbridge.com/en/news/286598101.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**